Proven leader will oversee research program designed to incorporate patient-reported experiences to impact research, clinical care, and outcomes
BOSTON, MA, August 15, 2017 – Alicia H. McAuliffe-Fogarty, PhD, CPsychol has been named vice president of patient-centered research for T1D Exchange, a Boston-based nonprofit organization uniting those affected by disease with those dedicated to accelerating better care and improved treatments. Dr. McAuliffe-Fogarty will drive research programs designed to understand the needs of people affected by type 1 diabetes, including burden of managing the disease and impact to health outcomes.
This addition to the organization’s leadership team comes as T1D Exchange is making a real and measurable difference in driving better, faster research to improve care and speed development of new therapies for people and families living with type 1 diabetes.
In her role Dr. McAuliffe-Fogarty will oversee patient-centered research priorities, strategy, and operations for research studies and patient insight programs designed to accelerate new product development, improve clinical care, and increase access to treatments and devices.
“Dr. McAuliffe-Fogarty is an accomplished executive and a true advocate to helping those living with chronic illnesses such as type 1 diabetes,” said Dana Ball, executive director and co-founder of T1D Exchange. “Dr. McAuliffe-Fogarty’s expertise, prior experience and education make her an outstanding complement to our team. She will strengthen our patient-centric research programs and help our organization continue to drive impactful, lasting results for patients living with type 1 diabetes.”
Prior to her role at T1D Exchange, Dr. McAuliffe-Fogarty served as the vice president of lifestyle management at the American Diabetes Association (ADA) where she provided clinical expertise, strategy and support for projects, programs, grants, sponsors, interviews, and presentations.
Dr. McAuliffe-Fogarty also served as the head of behavioral science at Human Care Systems, Inc. where she conducted research for pharmaceutical and device companies, bringing therapies to market and creating multi-channel support and education programs for patients and healthcare practitioners.
“I am thrilled to be joining the T1D Exchange team and to be part of such a forward-thinking nonprofit bringing people with type 1 diabetes into the center of research that will meaningfully impact their lives. This is a unique opportunity where I can leverage my strengths and experiences to further drive results and expand the reach of the already successful research program,” said Dr. McAuliffe-Fogarty.
About T1D Exchange
T1D Exchange was founded on the belief that people affected by type 1 diabetes need better solutions faster—better treatments and better care. Our nonprofit organization takes an innovative approach that puts the community of people touched by type 1 diabetes at the center of research that will meaningfully impact their lives. Our integrated model offers researchers access to aggregated clinical, biological, patient-reported outcomes and electronic health record data, all while fostering collaboration among patients, physicians, researchers and industry. Our model is multi-faceted and complex, but our goal is simple: to tangibly improve outcomes for people with type 1 diabetes as fast as humanly possible.